ADVAN'CE'D

Clinical trials for ADVAN'CE'D explained in plain language.

Never miss a new study

Get alerted when new ADVAN'CE'D trials appear

Sign up with your email to follow new studies for ADVAN'CE'D, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for stomach cancer: experimental combo targets advanced disease

Disease control Not yet recruiting

This study is for people with advanced stomach cancer that has gotten worse after their first treatment. It tests an experimental drug called IBI363, which helps the immune system fight cancer, combined with other drugs. The goal is to see if this combination is safe and can shri…

Matched conditions: ADVAN'CE'D

Phase: PHASE1, PHASE2 • Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control

Last updated May 03, 2026 05:30 UTC

ADVAN'CE'D

Get alerted when new ADVAN'CE'D trials appear

New hope for stomach cancer: experimental combo targets advanced disease